Objectives: The purpose of this study was to explore a novel disease gene for hypertrophic cardiomyopathy (HCM) and evaluate functional alteration(s) caused by mutations.
Introduction
Cardiomyopathy is a primary heart muscle disorder caused by functional abnormalities of cardiomyocytes. There are several clinical subtypes of cardiomyopathy and the most prevalent subtype is hypertrophic cardiomyopathy (HCM) [1, 2] . HCM is characterized by hypertrophy and diastolic dysfunction of cardiac ventricles accompanied by cardiomyocyte hypertrophy, fibrosis and myofibrillar disarray [1] . Although the etiology of HCM has not been fully elucidated, 50-70% of the patients with HCM have apparent family histories consistent with autosomal dominant genetic trait [2] , and recent genetic analyses have revealed that a significant percentage of HCM is caused by mutations in the genes encoding for myofilaments and Z-disc proteins of the cardiac sarcomere with the majority of mutations identified in MYH7-encoded beta myosin heavy chain and MYBPC3-encoded myosin binding protein C [2] .
ANKRD1 (ankyrin repeat domain 1)-encoded "cardiac adriamycin responsive protein" [3] or "cardiac ankyrin repeat protein"(CARP) [4] , is a transcription co-factor and an early differentiation marker of cardiac myogenesis, expressed in the heart during embryonic and fetal development. CARP expression is up-regulated in the adult hearts at end-stage heart failure [5] . In addition, increased CARP expression was found in hypertrophied hearts from experimental murine models [6, 7] . These observations suggest a pivotal role of CARP in cardiac muscle function in both physiological and pathological conditions. Although CARP is known to be involved in the regulation of gene expression in the heart, Bang et al. demonstrated that CARP located to both the sarcoplasm and nucleus, suggesting a shuttling of CARP in cellular components [8] .
Within the I-band region of sarcomere, CARP bound to both N2A domain of titin/connectin encoded by TTN and the N-terminal domain of myopalladin encoded by MYPN. Hence, titin/connectin and myopalladin function in part as anchoring proteins of "sarcomeric CARP" [8, 9] . Titin/connectin is the most giant protein expressed in the striated muscles, which is involved in sarcomere assembly, force transmission at the Z-disc, and maintenance of resting tension in the I-band region [10, 11] . In cardiac muscle, there are two titin isoforms, N2B and N2BA. The N2B isoform contains a cardiac specific N2B domain, and the N2BA isoform contains both N2B and N2A domains. Both N2A and N2B domains, within the extensible I-band region, function as a molecular spring that develops passive tension; the expression of N2B isoform results in a higher passive stiffness than that of N2AB isoform. We previously reported an HCM-associated mutation localizing to the N2B domain [12] , and Gerull et al. [13] reported other TTN mutations in the Z/I transition domain. These observations suggest that the I-band region of titin/connectin contains elastic components extending with stretch to generate passive force, which plays an important role in the maintenance of cardiac function.
Another protein that anchors CARP at the Z/I band is myopalladin, a cytoskeletal protein containing 3 proline-rich motifs and 5 Ig domains. The proline-rich motifs in the central part is required for binding to nebulin/nebulette, and the Ig domains at the N-terminus and C-terminus are involved in the binding to CARP and sarcomeric -actinin, respectively [8] . It was suggested that myopalladin played key roles in sarcomere/Z-disc assembly, myofibrillogenesis, recruitment of the other Z/I-band elements, and signaling in the Z/I-band [8] .
In this study, we analyzed unrelated patients with heretofore genotype-negative HCM for mutations in ANKRD1 and found 3 mutations that showed abnormal binding to myopalladin and titin/connectin. In addition, we searched for mutations in the recipcrocal CARP-binding N2A domain of titin/connectin and identified 2 HCM-associated mutations in TTN causing abnormal binding to CARP. We report here that abnormal CARP assembly in the cardiac muscles may be involved in the pathogenesis of HCM.
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Methods
Subjects
A total of 384 unrelated patients with HCM were included in this study. The patients were diagnosed based on medical history, physical examination, 12-lead electrocardiogram, echocardiography, and other special tests if necessary. The diagnostic criteria for HCM included LV wall thickness >13mm on echocardiography, in the absence of coronary artery disease, myocarditis, and hypertension. The patients had been analyzed previously for mutations in previously published myofilament-and Z-disc associated genes and no mutation was found in any of the known HCM-susceptibility genes (15) (16) (17) (18) . Ethnically-matched healthy individuals (400 and 300 from Japan and USA, respectively) were used as controls. Blood samples were obtained from the subjects after given informed consent. The protocol for research was 
Mutational analysis
Using intronic primers, each translated ANKRD1 exon was amplified by polymerase chain reaction (PCR) from genomic DNA samples. TTN exons 99 to 104 corresponding to the N2A domain including binding domains to CARP and p94/calpain were amplified by PCR in exon-by-exon manner. Sequence of primers and PCR conditions used in this study are available upon request. PCR products were analyzed by direct sequencing or by denaturing high performance liquid chromatography (DHPLC) followed by sequencing analysis. Sequencing was performed using Big Dye Terminator chemistry (version 3.1) and ABI3100 DNA Analyzer (Applied Biosystems, CA, USA).
Co-immunoprecipitation (co-IP) assay
We obtained cDNA fragments of human ANKRD1 and TTN by RT-PCR from adult heart mRNA. A wild-type (WT) full-length CARP cDNA fragment spanned from bp249 to bp1208 of GenBank Accession No. NM_014391 (corresponding to aa1-aa319). Three equivalent mutant cDNA fragments containing C to G (Pro52Ala mutation), C to T (Thr123Met mutation) or A to G (Ile280Val mutation) substitutions were obtained by primer-directed mutagenesis method. A WT TTN cDNA fragment encoding N2A domains (from bp25535 to bp26465 of NM_133378 corresponding aa8437-aa8747) was obtained and 3 TTN mutants carrying T to C (non disease-associated Ile8474Thr polymorphism), G to A (HCM-associated Arg8500His mutation) or G to A (HCM-associated Arg8604Gln mutation) substitutions were created by the primer-mediated mutagenesis method. The cDNA fragments of ANKRD1 were cloned into myc-tagged pCMV-Tag3 (Stratagene, CA, USA), while TTN and MYPN cDNA fragments were cloned into pEGFP-C1 (Clontech, CA, USA). These constructs were sequenced to ensure that no errors were introduced.
Cellular transfection and protein extractions were performed as described previously [14] , and co-IP assays were performed using the Catch and Release v2. Numerical data were expressed as means ± SEM. Statistical differences were analyzed using one-way ANOVA and Student's t test for paired values. Means were compared by independent samples t-tests without correction for multiple comparisons.
A p-value<0.05 was considered to be statistically significant.
Indirect immunofluorescence microscopy
All care and treatment of animals were in accordance with "Guidelines for the Care and Use of Laboratory Animals" published by the National Institute of Health (NIH Publication 85-23, revised 1985) and subjected to prior approval by the local animal protection authority. Neonatal rat cardiomyocytes were prepared as described previously [14] . Eighteen and 48 hours after the transfection, cardiomyocytes were washed with PBS, fixed for 15 min in 100% ethanol at -20°C. Transfected cells were incubated in blocking solution, and stained by primary rabbit anti-myc polyclonal Ab (1:100, Santa Cruz Biotechnology) and mouse anti--actinin monoclonal Ab (1:800, Sigma-Aldrich), followed by secondary sheep anti-rabbit IgG FITC-conjugated Ab 
Results
Identification of ANKRD1 (CARP) and TTN mutations in HCM
Eleven distinct sequence variations in ANKRD1 were identified among the 384 patients with HCM ( Figure 1A) . Four intronic variants, 2 non-synonymous substitutions and 1 synonymous variation were polymorphisms, because they were also found in the controls. A nonsense mutation (c.423C>T in exon 2 yielding Gln59ter) was found in 2patients with familial HCM and was absent in the controls, but was not co-segregated with the disease in both families, suggesting that they were not associated with HCM. In 
Clinical phenotypes
Clinical findings of the patients carrying the ANKRD1 or TTN mutations are summarized in Table 1 . All patients manifested with HCM except CM1288 II-2 who had mild cardiac hypertrophy. Her father had died suddenly of unknown etiology at the age of 30. Two unaffected brothers of the patient did not harbor the mutation (Figure 1C) . The proband patient with the TTN Arg8606Gln mutation (CM1480 , Table 1 ) showed asymmetric septum hypertrophy. A family study revealed that his father had unexplained sudden cardiac death. His son (CM1481, Table 1 ) was affected and carried the same mutation ( Figure 1D ). (Figure 2A and B) . Reciprocally, the effect of titin/connectin mutations in binding to CARP was assessed. TTN-N2A constructs, WT-, HCM-associated mutants 
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Discussion
CARP encoded by ANKRD1 is a nuclear transcription co-factor expressing in the embryonic hearts. Its expression progressively decreases in adult hearts [3, 4] and reappears in the hypertrophied or failing adult heart [5, 15] , suggesting that CARP may be involved in the regulation of muscle gene expression. CARP also localizes in cardiac sarcomere although the roles of "sarcomeric CARP" are not fully elucidated. Several reports have demonstrated that CARP binds titin/connectin [9] , myopalladin [8] and desmin [16] at the Z/I-region of sarcomere. In this study, we found that the CARP constructs were fixed 48 h after the transfection, and stained with DAPI and anti--actinin antibody followed by secondary antibody (B, E, H, and K). Merged images were shown in C, F, I, and L. In the mature cardiomyocytes showing myofibrils with Z-discs, normal localization of myc-tagged WT CARP at the Z-discs was observed (A-C). In contrast, myc-tagged mutant CARP proteins showed intense localization at the I-discs (colocalization with -actinin) and diffused localization in the cytoplasm (D-F, G-I and J-L). In addition, myc-tagged mutant CARPs expressed at high levels around the nuclear membrane (white arrow) and/or in the nucleus (white arrowhead).
Conclusions
We identified 3 missense CARP mutations in < 1% of unrelated patients with HCM, which not only increased the binding of sarcomeric CARP to I-band components but also resulted in the mis-localization of CARP to the nucleus. Although the molecular mechanisms of HCM due to the CARP mutations remain to be elucidated, our findings imply that HCM may be associated with the abnormal recruitment of CARP in cardiomyocytes leading to pathological hypertrophy.
